Skip to main content
. Author manuscript; available in PMC: 2014 Jul 16.
Published in final edited form as: Oncogene. 2013 Jan 14;33(3):347–357. doi: 10.1038/onc.2012.586

Table 3.

Summary frequent mutations in EAC discovered by NGS

Gene/gene complex Mutation rate Type of mutation (absolute amount)
Reference(s)
Nonsense Indel Missense Splice site
APC 16.7% 1 1 0 0 Agrawal et al40
ARID1A 16.7% 2 0 0 0 Agrawal et al40, this paper
BRSK1 16.7% 0 1 1 0 Agrawal et al40
FBN3 16.7% 1 0 1 0 Agrawal et al40
MUC16 16.7% 1 0 1 0 Agrawal et al40
HMCN1 25.0% 0 0 3 0 Agrawal et al40
HTR1A 25.0% 0 0 3 0 Agrawal et al40
ANK2 25.0% 0 0 2 1 Agrawal et al40
SYNE1 33.3% 0 0 4 0 Agrawal et al40, this paper
KIF2B/CLASP1 41.7% 0 0 5a 0 Agrawal et al40, this paper
TP53 75.0% 2 1 3 3 Agrawal et al40, this paper

An overview of prevalent mutations in EAC identified using NGS by Agrawal et al40 and our group. In total, 12 EAC and matched NSE tissue samples were utilized for NGS. Genes in which nonsense and indel mutations were detected in at least 2/12 (16.7%) patients as well as genes in which missense or splice site mutations occurred in >3 cases (25%) are listed in this table. Abbreviations: ARID1A, AT-rich interactive domain 1A (SWI like); EAC, esophageal adenocarcinoma; NGS, next-generation sequencing; NSE, normal squamous epithelium of the esophagus.

a

CLASP1 mutation was found in only one patient.